NGF-TrkA轴通过miR-29b-3p抑制增强骨髓瘤中PDGF-C介导的血管生成:使用拉罗特雷克提尼布的潜在治疗策略
Sheng-Mou Hou1,2, Ching-Yuan Cheng3, Wei-Li Chen4
1Department of Research, Taiwan Blood Services Foundation, Taipei 111, Taiwan.
Life (Basel, Switzerland)
|January 25, 2025
概括
神经生长因子 (NGF) 通过上调PDGF-C和抑制miR-29b-3p促进骨髓瘤 (OS) 血管生成. TrkA抑制剂拉罗特雷克提尼布显示出治疗OS中NGF驱动的血管生成的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 血管新生对于骨髓瘤 (OS) 的进展和转移至关重要.
- 神经生长因子 (NGF) 在OS血管生成中的作用尚不清楚.
研究的目的:
- 研究NGF对骨髓瘤血管生成及其分子机制的影响.
- 在OS中确定NGF介导血管生成的潜在治疗点.
主要方法:
- 对OS组织中的血管新生标志物GEO数据集 (GSE16088) 的分析.
- 在体外实验中使用HUVEC和MG63细胞来评估NGF的血管效应.
- 研究了血小板衍生生长因子C (PDGF-C) 和微RNA-29b-3p (miR-29b-3p) 的作用.
- 利用TrkA抑制剂larotrectinib来评估其对细胞迁移和入侵的影响.
主要成果:
- NGF显著增强了HUVEC管的形成,表明血管生成能力增加.
- 在OS细胞中NGF上调调节了PDGF-C表达,并抑制了miR-29b-3p.
- 拉罗特雷克提尼布剂量依赖地抑制了MG63/NGF细胞的迁移和入侵.
- 发现NGF-TrkA轴通过miR-29b-3p抑制促进PDGF-C介导的血管生成.
结论:
- NGF-TrkA信号通路在促进骨髓瘤血管生成方面发挥着关键作用.
- 准NGF-TrkA轴,可能是用larotrectinib,为OS提供了一个有前途的治疗策略.
相关概念视频
Enzyme-linked Receptors
77.1K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


